Clinical Trials

Aging mammary stem cells and breast cancer prevention

Cancer Type

Breast

ClinicalTrials.gov Identifier

NCT02642094

Principal Investigator

Ismail Jatoi M.D.

For more information about this study
View Details

About This Study

To examine whether rapamycin can reduce malignant markers and aberrant mammary stem/progenitor cells (MaSCs) number in surgical specimens